C000193819 Holdings — Transamerica Levin Large Cap Value VP
All 45 reported holdings of Transamerica Levin Large Cap Value VP (C000193819) by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets | Value (USD) |
|---|---|---|
| Amazon.com Inc | 6.25% | $5.50M |
| Apple Inc | 5.26% | $4.63M |
| Microsoft Corp | 4.23% | $3.72M |
| JPMorgan Chase & Co | 3.74% | $3.29M |
| Exxon Mobil Corp | 3.30% | $2.90M |
| RTX Corp | 2.79% | $2.45M |
| Wells Fargo & Co | 2.73% | $2.40M |
| Quanta Services Inc | 2.66% | $2.34M |
| Linde PLC | 2.64% | $2.32M |
| Parker-Hannifin Corp | 2.61% | $2.30M |
| Merck & Co Inc | 2.52% | $2.22M |
| Goldman Sachs Group Inc/The | 2.52% | $2.21M |
| Delta Air Lines Inc | 2.45% | $2.15M |
| CSX Corp | 2.44% | $2.15M |
| TJX Cos Inc/The | 2.43% | $2.14M |
| Blackrock Inc | 2.36% | $2.07M |
| Hartford Insurance Group Inc/The | 2.24% | $1.97M |
| Bank of America Corp | 2.21% | $1.94M |
| Rockwell Automation Inc | 2.11% | $1.86M |
| Alphabet Inc | 2.08% | $1.83M |
| General Motors Co | 2.03% | $1.78M |
| Martin Marietta Materials Inc | 1.96% | $1.72M |
| Micron Technology Inc | 1.91% | $1.68M |
| Walt Disney Co/The | 1.89% | $1.66M |
| PepsiCo Inc | 1.88% | $1.66M |
| Gilead Sciences Inc | 1.83% | $1.61M |
| Abbott Laboratories | 1.78% | $1.57M |
| Boeing Co/The | 1.70% | $1.49M |
| Duke Energy Corp | 1.67% | $1.47M |
| AbbVie Inc | 1.65% | $1.45M |
| ConocoPhillips | 1.65% | $1.45M |
| Fox Corp | 1.62% | $1.43M |
| Intercontinental Exchange Inc | 1.61% | $1.42M |
| Meta Platforms Inc | 1.56% | $1.37M |
| Thermo Fisher Scientific Inc | 1.54% | $1.36M |
| Cencora Inc | 1.51% | $1.33M |
| Lowe's Cos Inc | 1.50% | $1.32M |
| Prologis Inc | 1.44% | $1.27M |
| Freeport-McMoRan Inc | 1.44% | $1.27M |
| Motorola Solutions Inc | 1.35% | $1.19M |
| Broadcom Inc | 1.21% | $1.06M |
| American Tower Corp | 1.16% | $1.02M |
| Mondelez International Inc | 1.12% | $981.66K |
| Textron Inc | 1.10% | $964.63K |
| Constellation Energy Corp | 0.78% | $682.77K |
C000193819 overview: performance, fees, allocation and SEC filings